An observational study in Taste, Altered, sponsored by University of Minnesota. Withdrawn. Open to participants aged 8 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-25.
Sponsored by University of Minnesota · Observational
To determine if patient satisfaction, participation, and image quality improves with flavored oral contrast for MR enterography.
Volumen is an oral contrast agent used in MR imaging of the bowel. It has an unpleasant taste which makes it difficult for pediatric patients, especially sick pediatric patients, to drink. There are other contrast materials used in the department that are flavored to improved patient participation. The investigators hope to determine a way to flavor Volumen to improve patient participation. In doing so, the investigators hope to also improve patient satisfaction as well as imaging quality.
52 studies on the registry are indexed under Dysgeusia; 12 are open to participants now.
Browse Dysgeusia studies →University of Minnesota is the lead sponsor of 1,216 studies on the registry; 197 are open to participants now.
Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Pediatric patients undergoing MR enterography examinations
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group of patients will have the choice to flavor their contrast.
This group of patients will drink the contrast without flavoring.
the number of patients that prefer flavored contrast
the number of patients that prefer flavored contrast will be evaluated by a questionaire
Time frame: one year
bowel diameter measurements on MR Enterography
bowel diameter measurements will be made by two radiologists on MR Enterography
Time frame: one year
No study locations are listed for this record.
The record gives a start of Jan 2016, a primary completion of Dec 2016 and a completion of Dec 2016. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.